Early Autism Diagnosis Could be Possible With New Blood and Urine Tests
The detection of damaged proteins in blood and urine tests could help to diagnose autism…
21/02/2018 - 3 minutes
Alex Dale
A former journalist intern at Labiotech, Alex now works as a copywriter in healthcare advertising. When he's not writing, he enjoys playing sports and long-distance cycling.
A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs
Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for…
20/02/2018 - 3 minutes
This Gene Therapy for Vision Loss is Safe and Effective After Two Years
The results of a long-term follow-up suggest that GenSight's gene therapy for Leber hereditary optic…
20/02/2018 - 3 minutes
The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease
The FDA has awarded Hansa Medical's lead candidate for the treatment of an autoimmune disease…
19/02/2018 - 2 minutes
Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?
Two clinical studies have demonstrated the capacity of Novartis' monoclonal antibody to treat both plaque…
19/02/2018 - 3 minutes
This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline
UCB has presented positive Phase IIb results for its psoriasis drug, bimekizumab, and outlined the…
19/02/2018 - 3 minutes
Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets
Scientists in London are the first in the world to test how pathogens like the…
19/02/2018 - 3 minutes
This Bavarian Biotech Offers Better Drug Delivery to Boost Efficacy and Tolerability
This week, we're in the Bavarian region of Germany to check out XL-Protein, a biotech that…
16/02/2018 - 2 minutes
Startup Studio Raises €90M to Create and Develop Exciting Young Biotechs
iBionext has closed its Growth Fund, which has raised money from investors like Bpifrance to…
15/02/2018 - 3 minutes
This Biotech Veteran Is Using These Tips for Successful Drug Development, Here Is Why
Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate…
14/02/2018 - 5 minutes
Anti-Antibiotic Resistance Technology Gets Fast-Tracked to Phase III
Allecra Therapeutics' candidate that blocks the development of antibiotic resistance has been awarded the FDA's Fast…
14/02/2018 - 2 minutes
Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors
A collaboration between Bicycle Therapeutics and Cancer Research UK has yielded its first peptide to…
14/02/2018 - 3 minutes
